Trial intelligence / Profile preview

Chai Qin Qing Ning Capsule for Cold with Fever

ChiCTR-IPR-16009049Phase 4Recruiting

Sponsor
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Start
Jan 2016
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Chaiqin Qingning in upper respiratory infection (URI) (2 arms), sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Primary endpoints: Antipyretic effect time and Time to body temperature normalization. Started Jan 2016; status: recruiting.

02

Drugs

Chaiqin Qingning
03

Conditions

upper respiratory infection (URI)

Beyond the preview

Go deeper on ChiCTR-IPR-16009049.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-16009049.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call